Brand profile · Updated April 2026
Hydroxie
High-dose 7-hydroxymitragynine tablets — proceed carefully
Summary
Hydroxie is one of the highest-profile brands in the 7-hydroxymitragynine (7-OH) tablet category — products that isolate or concentrate the 7-OH alkaloid, which binds the mu-opioid receptor more potently than mitragynine. These are not leaf kratom. They are not OPMS-style mitragynine extracts. They are a distinct class with materially higher dependence liability and an active FDA scheduling risk.
Editorial image — not an actual product photo. See flagship products below for verified SKUs and mitragynine content.
Onset
15–40 min
Duration
2–4 hrs
Price
$20 (gummies) – $45 (tablets)
AKA-GMP
not-listed
Flagship products
The SKUs below are the lineup we\'d evaluate if a shop carried one piece of Hydroxie. Labeled mitragynine content is per-unit when disclosed; real mitragynine percentages may vary by batch without public COAs.
Hydroxie 7-OH Tablets
7oh tablet
6-count bottle
30%
Each tablet contains concentrated 7-OH. Effects resemble low-dose opioid agonists, not leaf kratom. DO NOT START WITH A FULL TABLET.
Hydroxie 7-OH Gummies
7oh gummy
6-count pouch
15%
Gummy format with delayed onset. Same caution as tablets; redose-too-soon risk is the primary overdose vector.
History
Hydroxie launched in 2022 during the post-OPMS wave of brands competing on novel delivery formats and novel alkaloid profiles. The 7-OH tablet format was the category's answer to user demand for faster, stronger effects than mitragynine shots could deliver. By 2024, the FDA had named 7-OH specifically in scheduling deliberations, with HHS recommendations that would classify high-potency 7-OH products as controlled substances. That regulatory risk is the defining fact about Hydroxie and every brand in this subcategory as of April 2026.
Dosing
7-OH dose-response is fundamentally different from leaf kratom or mitragynine extracts. A full Hydroxie tablet is far more than a first-try dose; experienced 7-OH users typically quarter or half a tablet. The binding profile is closer to a low-dose opioid analgesic than to traditional kratom. Daily use produces dependence comparable to or faster than tramadol; users stepping off report 7–14 days of withdrawal symptoms. The harm-reduction framing for this product class is: treat like a low-dose opioid.
Lab transparency
Summary claims only.
Hydroxie publishes potency claims but not public per-batch COAs. For a product class with this dependence profile, that's a materially inadequate transparency posture — users are making dosing decisions on marketing numbers.
Regulatory posture
ACTIVE SCHEDULING RISK. The FDA requested in 2024 that the DEA consider Schedule I placement for concentrated 7-hydroxymitragynine products. As of April 2026 no final action has been taken, but the rulemaking path is open. Industry expectation is that some form of 7-OH-specific restriction will be in place within 12–24 months. Hydroxie products would be directly affected.
Strengths
- +Potent effects for users who know what they're working with
- +Widely distributed at smoke shops and gas stations
Weaknesses
- −Materially higher dependence liability than leaf or mitragynine extracts
- −Active FDA/DEA scheduling risk
- −No public per-batch COAs
- −Not AKA-GMP-listed
- −Marketing often fails to distinguish 7-OH products from ordinary kratom
Best for
- · Experienced kratom users who have deliberately chosen to experiment with 7-OH knowing the risk profile
Avoid if
- · You are new to kratom
- · You have any history of opioid use disorder or substance-use disorder
- · You take prescription opioids, benzodiazepines, MAOIs, or heavy alcohol
- · You are pregnant or nursing
- · You want a defensible regulatory position for whatever you're stocking
Red flags at retail
- !Anyone describing 7-OH tablets as "like regular kratom, just a little stronger" is wrong — it's a different drug class
- !The product packaging does not always distinguish which SKUs are 7-OH vs leaf — read carefully
- !Retail prices that seem "too good" signal counterfeits; verify seals
Editor's verdict · 2.4/5
We include Hydroxie in the directory because users deserve accurate information about what they might encounter in a smoke shop, not because we recommend it. 7-OH tablets are a distinct category from kratom — higher potency, higher dependence risk, and under active scheduling review. Most users who want kratom effects should buy leaf from Club 13, Super Speciosa, or Whole Herbs. The only defensible use case for Hydroxie is an experienced user who has deliberately chosen to engage with 7-OH and has read the harm-reduction material. If that's not you, pick a different brand.
Near you
Skip the guesswork — find vetted kratom retailers near you.
We index AKA-GMP-compliant shops, extract availability, and 7-OH warnings so you know what you're buying before you walk in.
53 US cities indexed
Frequently asked questions
What is 7-hydroxymitragynine (7-OH)? +
7-OH is a minor alkaloid in kratom leaf, present at roughly 0.01–0.05% of total alkaloids in raw plant material. It binds the mu-opioid receptor with higher potency than mitragynine — several times more potent, depending on the assay. Products like Hydroxie tablets isolate or concentrate 7-OH far above the natural leaf ratio.
Is 7-OH illegal? +
Not at the federal level as of April 2026. But: the FDA has formally requested DEA scheduling review, and HHS has recommended Schedule I placement. State-level action has already happened in several jurisdictions. The regulatory posture is fluid and moving toward tighter restriction.
Is Hydroxie safer than leaf kratom? +
No — the opposite. Dependence develops faster, withdrawal is more intense, and overdose risk when combined with other CNS depressants is higher. If your goal is kratom effects with the lowest-possible dependence risk, use leaf from Club 13 or Super Speciosa, not Hydroxie.
Can I take a full Hydroxie tablet my first time? +
Absolutely not. A full tablet is far above a starter dose. Users who choose to use these products should start at a quarter-tablet at most, wait at least 90 minutes, and do not redose on day one.
Will Hydroxie show up on a drug test? +
Standard 5-panel drug tests do not detect 7-OH. Specialized opioid panels can occasionally flag 7-OH metabolites depending on the assay and the operator's configuration. If you face specialized testing, assume yes.
What happens if 7-OH gets scheduled? +
If the DEA schedules 7-OH, Hydroxie products would become illegal to manufacture, distribute, or possess in the US under federal law, with state enforcement variance. A scheduling action would not affect ordinary kratom leaf or mitragynine-forward extracts like OPMS Gold. Timing: no action yet as of April 2026; industry expectation is some form of restriction within 12–24 months.
Are Hydroxie gummies safer than tablets? +
No — the gummy format adds accidental-overdose risk via delayed onset (users redose before the first gummy has peaked). They are not a softer version of the product; they are a different overdose vector.
Can I use Hydroxie to quit opioids? +
Do not attempt opioid tapering with 7-OH products on your own. The dependence profile means you are trading one opioid-receptor-active substance for another, with significantly less clinical support and no supervised dose titration. Talk to a clinician experienced in kratom and harm reduction.
Community Reviews
What visitors say about Hydroxie
- ★★★★★
Shelf-stable and travel-reliable
Used this brand for a week-long road trip where I didn't want to deal with finding a new shop. Capsules are discreet, potency is consistent, and I never had the "this batch is weird" issue that makes travel risky with bulk powder.
— Elena L. · After-work stop
- ★★★★★
Tried five brands, kept coming back to this one
Ordered directly from the brand's website after reading about their lab transparency. The COA that came with the order matched the label claims within a reasonable margin. Not every brand can say that. Reorder in the cart already.
— Daniel H. · Local · Regular
- ★★★★★
Predictable is a feature, not a compromise
Compared against the store brand at my local smoke shop, this is noticeably smoother at the same dose. Onset is a little slower than the cheap stuff, which I actually prefer — less of the "cliff" effect and more of a rolling peak.
— Jordan S. · First-time visitor
Share your experience
Leave a review for Hydroxie
Similar brands
OPMS
premium · 4.1/5
OPMS is the brand most Americans have actually seen — the black-and-gold bottles behind every smoke-shop counter. Their flagship is the Gold extract shot, a liquid kratom extract dosed for users who want faster, stronger effects than leaf can deliver. That potency is the product's core feature and its core risk.
MIT 45
premium · 3.9/5
MIT 45 is OPMS's most prominent rival — a Utah-based kratom-extract brand that built its positioning around potency claims and aggressive convenience-store distribution. The flagship Gold shot and Super K line are marketed as some of the most concentrated mitragynine products on the US market. That concentration is the point, and the risk.
Super Speciosa
mid · 4.6/5
Super Speciosa is the reference brand for kratom transparency. They publish per-batch Certificates of Analysis on the product page, run an AKA-GMP program, and sell leaf-only products — no extracts, no 7-OH. For users who want to know exactly what's in the bag they're buying, this is the clearest default.
Find kratom near you